Francisco Chacón-Lozsán: From Protocols to Physiology in Septic Shock
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine (ESICM) and American College of Cardiology, shared a post on LinkedIn about a recent article by Glenn Hernandez, published in Critical Care, adding:
“Septic shock resuscitation is entering a new era. Physiology is replacing protocols.
For more than two decades, septic shock research has challenged one assumption after another. We targeted central venous oxygen saturation.
We targeted lactate. We targeted mean arterial pressure. We restricted fluids.
Yet despite these advances, improvements in patient-centered outcomes remained inconsistent.
This remarkable perspective from many of the world’s leading experts argues that the problem was never the individual variables.
The problem was expecting a single physiological target to represent an extraordinarily heterogeneous disease.
The evolution of septic shock management tells an important story.
Early Goal Directed Therapy demonstrated that protocolized resuscitation could improve outcomes, but subsequent multicenter trials showed that fixed algorithms cannot account for the diversity of septic shock phenotypes.
Lactate proved invaluable for risk stratification but increasingly unreliable as an isolated treatment target beyond the initial hours of resuscitation.
Mean arterial pressure also evolved from a universal threshold to an individualized physiological variable whose optimal value depends on the patient’s underlying cardiovascular state.
The most important conceptual shift has been moving from treating numbers to treating perfusion.
Capillary refill time emerged as a rapidly responsive bedside marker that reflects the adequacy of tissue reperfusion.
The ANDROMEDA-SHOCK program demonstrated that combining capillary refill time with systematic assessment of fluid responsiveness, focused critical care echocardiography, and sequential hemodynamic phenotyping allows clinicians to individualize therapy while reducing unnecessary interventions.
Another major lesson is that fluids are no longer considered inherently beneficial. Every fluid bolus should answer a physiological question.
Is the patient fluid responsive? Will the patient tolerate additional volume?
Is venous congestion already limiting organ perfusion?
Fluid administration has evolved from a routine intervention into a reversible physiological test.
Perhaps the strongest message of this review is that hemodynamic resuscitation is no longer protocol driven but physiology guided.
Septic shock should be understood as a dynamic process requiring repeated cycles of observation, bedside testing, intervention, and reassessment.
The future of resuscitation will not be defined by new numbers, but by a deeper understanding of physiology.”
Title: Twenty-five years of septic shock hemodynamic resuscitation trials: a conceptual perspective
Authors: Glenn Hernandez, Oliver Hunsicker, Daniel de Backer, Derek C. Angus, Jan Bakker, John Basmaji, Ricardo Castro, Michelle Chew, Olfa Hamzaoui, Manu L. N. G. Malbrain, Paulo Melo, Antonio Messina, Xavier Monnet, Sebastian Morales, Gustavo A. Ospina-Tascón, Marlies Ostermann, Michael R. Pinsky, Zbigniew Putowski, Filippo Sanfilippo, Jean-Louis Teboul, Pedro Wendel-García, Eduardo Kattan
Other posts featuring Francisco Chacón-Lozsán on Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience